当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
FluBlok, Influenza Vaccine
申请企业
Protein Sciences Corporation
药品名称
FluBlok, Influenza Vaccine
承诺描述
To perform a retrospective cohort study (VAP00007) to evaluate the safety of Flublok Quadrivalent influenza vaccine in pregnant women and their offspring exposed during pregnancy or up to 28 days preceding the estimated date of conception with regards to pregnancy, birth, and neonatal/infant outcomes.